Skip to main content
Clinical Trials/CTRI/2009/091/000932
CTRI/2009/091/000932
Completed
Phase 3

A Multicentric, Randomized, Comparative Clinical Trial to Evaluate the Efficacy and Safety of Dexketoprofen ER Tablet in the Treatment of Osteoarthritis

Emcure Pharmaceuticals Ltd, Pune0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Emcure Pharmaceuticals Ltd, Pune
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Emcure Pharmaceuticals Ltd, Pune

Eligibility Criteria

Inclusion Criteria

  • ? Male or female patients between 40\-75 years of age.
  • ? Willing to give written informed consent and willing to comply with trial protocol.
  • ? Clinically and/or radiologically diagnosed to have OA or are known OA patients
  • ? Patient and / or physician?s global assessment of arthritic condition as fair, poor or very poor.
  • ? Patients with normal laboratory values.
  • ? Patients not on any anti\-inflammatory or other therapy known to affect the study outcome.

Exclusion Criteria

  • ? Patients with history of any drug allergy or intolerance to NSAIDs.
  • ? Severe hypertension or uncontrolled hypertension
  • ? Patients with H/O or evidence of renal, hepatic or neurologic diseases
  • ? Uncontrolled diabetes
  • ? Women who are pregnant, lactating, of child bearing potential who are not practicing effective methods of contraception.
  • ? Any condition that, in the opinion of the investigator, does not justify the patient?s inclusion in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials